AT
MRNA icon

Arlington Trust’s Moderna MRNA Stock Holding History

Arlington Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2K Hold
60
– – ﹤0.01% 583
2026
Q1 		$3.05K Buy
+60
New +$2.8K ﹤0.01% 599
2025
Q2 		– Sell
-290
Closed -$8.22K – 724
2025
Q1 		$8.22K Hold
290
– – ﹤0.01% 522
2024
Q4 		$12.1K Hold
290
– – ﹤0.01% 454
2024
Q3 		$19.4K Hold
290
– – ﹤0.01% 406
2024
Q2 		$34.4K Hold
290
– – 0.01% 361
2024
Q1 		$30.9K Sell
290
-6
-2% -$605 0.01% 308
2023
Q4 		$29.4K Buy
296
+290
+4,833% +$24.4K 0.01% 322
2023
Q3 		$620 Buy
+6
New +$669 ﹤0.01% 318

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Arlington Trust's MRNA Position: Q2 2026 in Review

Arlington Trust held its Moderna (MRNA) position steady in Q2 2026 at 60 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Arlington Trust first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $34.4K in Q2 2024. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Arlington Trust held 60 shares of Moderna worth $4.2K as of Q2 2026.
  • Arlington Trust left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #583 holding.
  • Arlington Trust first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
  • Arlington Trust's Moderna position peaked at $34.4K in Q2 2024.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.